Read our latest publications

Prioritisation Process Report for Older Australians

For the review of the evidence for dietary guidance for older Australians.

Published in June 2024.

  • Report

Embryo Research Licensing Committee Report to Parliament - 1 September 2023 to 29 February 2024

The 43rd biannual report

  • Embryo Research Licensing Report

Top 10 in 10 publications policy evaluation report

In 2021, NHMRC undertook a targeted consultation on NHMRC’s assessment of publications. Based on the results of this consultation, NHMRC began implementing a new policy relating to the assessment of publications for its track record-based schemes.

The new policy limited applicants to list no more than 10 of their top publications in the past 10 years. The Top 10 in 10 publications policy evaluation report – which may be downloaded at the bottom of this page – describes the results of a process evaluation that sought to determine whether the policy has been implemented as intended. 

  • Report

10 of the Best – Fifteenth Edition

10 of the Best NHMRC research projects – Fifteenth Edition celebrates the calibre of talent and achievements of Australia’s health and medical researchers. 

  • 10 of the Best

Guidelines approved under Section 95A of the Privacy Act 1988

The Guidelines approved under Section 95A of the Privacy Act 1988 are issued for the purposes of Australian Privacy Principles (APPs) and sections 16B(2) and 16B(3) of the Privacy Act.

  • Guideline
  • Current

Guidelines approved under Section 95AA of the Privacy Act 1988 (Cth)

The Privacy Legislation Amendment Act 2006 (Cth) made changes to the Privacy Act 1988(Cth) (the Privacy Act) to allow health practitioners to disclose patient’s genetic information, whether or not they give consent, in circumstances where there is reasonable belief that doing so is necessary to lessen or prevent a serious threat to the life, health or safety of their genetics relative(s).  The amendments do not oblige disclosure of information but provide the framework for this to occur under the appropriate circumstances.

  • Guideline
  • Current

Guidelines under Section 95 of the Privacy Act 1988

These guidelines provide a framework in which medical research involving personal information obtained by Commonwealth agencies should be conducted, to ensure the information is protected.

  • Guideline
  • Current

Research Impact Track Record Assessment (RITRA) framework Evaluation Report

NHMRC’s Research Impact Track Record Assessment (RITRA) framework requires researchers to report on past research impacts in their applications for Investigator and Synergy Grants and requires peer reviewers to assess and score these reported impacts.

Implementation of this framework is intended to provide an incentive for researchers to consider future impact when planning and conducting research, ideally leading to an increase in the translation of NHMRC-funded research and improved public health.

The RITRA framework evaluation report describes the results of a process evaluation that sought to determine whether the RITRA framework has been implemented as intended.

  • Report
"

Embryo Research Licensing Committee Report to Parliament - 1 March to 31 August 2023

The 42nd biannual report

  • Embryo Research Licensing Report
  • Current
""

Direct Research Cost Guidelines

The Direct Research Cost (DRC) Guidelines (Guidelines) set out the general principles that researchers, Research Administration Officers and Finance Officers should use to guide the appropriate allocation of NHMRC funds for salaries and stipends, and to determine whether expenses are DRCs for the NHMRC funded Research Activity.

  • Policy
  • Current
Artwork attribution: Jordan Lovegrove, Indigenous artist. The artwork for the NHMRC work in Indigenous health and medical research communicates empowerment of people over their health and the progression of learning and knowledge out from the meeting place (NHMRC—bottom left corner), where many people are gathered. In the streams there are the sources of nutrition and health—ants, berry bush and fish, as well as stars, which symbolise new ideas.

IREC Review Consultation Report

The purpose of this report is to provide a summary of feedback received as part of the national consultation to review NHMRC’s Indigenous Research Excellence Criteria (IREC).

  • Report
  • Current

Evidence review strategy - Review of the 2013 Australian Dietary Guidelines

Evidence review strategy for the review of the 2013 Australian Dietary Guidelines. A summary map of the evidence review process is available in the Downloads section.

  • Report

10 of the Best – Fourteenth Edition

10 of the Best NHMRC research projects – Fourteenth Edition describes 10 Australian health and medical research projects chosen from among the thousands of NHMRC-funded medical research projects underway in Australia.

  • 10 of the Best

Post-implementation review survey results, Postgraduate Scholarships 2019-2022

The following data has been obtained from the 2019-2022 Postgraduate Scholarships (PGS) post-implementation review (PIR) surveys of peer reviewers. This document summarises key trends in these findings and details areas for improvement to better shape PGS peer review practices in the future.

  • Factsheet
  • Current

Annual Report 2022-23

This report contains information on NHMRC administration and performance, and a record of our activities for the reporting period 2022–23.

An accessible version of this document is available on the Transparency Portal.

  • Annual report

Grantee Variations Policy

The NHMRC Grantee Variations Policy details our policy on varying a grant. It includes how to submit a grantee variation request. Types of variations are also listed.

  • Policy
  • Current

NHMRC Corporate Plan 2023–24

The NHMRC Corporate Plan 2023–24 presents our strategy for building a healthy Australia, across the strategic themes (purposes) of investment, translation and integrity of health and medical research. The plan also includes our strategic and health priorities, as well as our key activities planned for 2023–24 and over the next four years. The plan describes the operating context in which we work and outlines our performance criteria and targets for the next 4 years.

The key elements of our Corporate Plan 2023–24 are summarised in the Plan on a Page.

  • Corporate Plan

Prioritisation Process Report

For the review of the evidence underpinning the Australian Dietary Guidelines.

Published in June 2023.

  • Guideline
decorative image

Indigenous Research Excellence Criteria (IREC) Review - Discussion Paper

NHRMC opened a national consultation in 2023 to review the Indigenous Research Excellence Criteria (IREC). This discussion paper was produced to inform the review. It provides information on the IREC and lists the consultation questions.

  • Current
""

Embryo Research Licensing Committee Report to Parliament - 1 September 2022 to 28 February 2023

The 41st biannual report.

  • Embryo Research Licensing Report
  • Current
Decorative image - Avatars in virtual terrain

National Statement on Ethical Conduct in Human Research 2023

The National Statement on Ethical Conduct in Human Research (2023) consists of a series of guidelines made in accordance with the National Health and Medical Research Council Act 1992.

  • Statement
  • Current

NHMRC grants with international collaborators 2012 to 2021

The purpose of this report is to provide a descriptive analysis of the scope and reach of the National Health and Medical Research Council's (NHMRC) international collaborations across all grant schemes over the past 10 years.

  • Report
  • Current

International Engagement Strategy 2023–2026 – strategic opportunities

Developed through consultation with other Australian Government agencies, our Strategic Opportunities report outlines more specific and targeted initiatives that National Health and Medical Research Council (NHMRC) could undertake to achieve the actions and goals set out in the International Engagement Strategy 2023–2026.

  • Current
decorative image

Consumer and community representatives participation in peer review panels

This information booklet provides guidance on how the Targeted Calls for Research (TCR) peer review process works, what is involved, and the role and responsibilities of consumer and community representatives (CCRs) on peer review panels.

  • Current

Outcomes of the 2021 Call for Submissions for Research Translation Centre accreditation

The National Health and Medical Research Council (NHMRC) established the Research Translation Centre Initiative (the Initiative) in 2014 as a key mechanism for supporting the translation of health and medical research in Australia.

  • Report
  • Current

Policy on Consumer and Community Participation in Peer Review

The National Health and Medical Research Council (NHMRC) engages with health consumer and community groups to identify community representatives, consumers and/or carers to participate in our committees, peer review processes, guideline development and public consultation.

  • Policy
  • Current

10 of the Best – Thirteenth Edition

10 of the Best NHMRC research projects – Thirteenth Edition describes 10 Australian health and medical research projects chosen from among the thousands of NHMRC-funded medical research projects underway in Australia.

  • 10 of the Best
decorative image

Embryo Research Licensing Committee Report to Parliament – 1 March to 31 August 2022

The 40th biannual report

  • Embryo Research Licensing Report

Annual Report 2021-22

This report contains information on NHMRC administration and performance, and a record of our activities for the reporting period 2021–22.

An accessible version of this document is available on the Transparency Portal.

  • Annual report

Consultation report: Options to reach gender equity in the Investigator Grant scheme

This consultation report provides the outcomes of NHMRC’s national consultation on options to reach gender equity in the Investigator Grant scheme.

  • Current

NHMRC Corporate Plan 2022–23

The National Health and Medical Research Council (NHMRC) Corporate Plan 2022–23 presents our national strategy for health and medical research aligned with our three strategic purposes of investment, translation and integrity. The plan also includes our strategic priorities and health priorities and outlines our key activities planned for 2022–23 and over the next four years. In addition, the plan describes the operating context in which we work and our performance criteria and targets for the next four years

  • Corporate Plan
decorative image

Reconciliation Action Plan 2022-24

Our commitment to improving the health of Aboriginal and Torres Strait Islander peoples covers all aspects of NHMRC’s responsibilities, as well as contributing to the Australian Government’s National Aboriginal and Torres Strait Islander Health Plan 2021-2031. 

  • Statement
  • Current
decorative image

Discussion paper: Options to reach gender equity in the Investigator Grant scheme

This Discussion Paper: Options to reach gender equity in the Investigator Grant scheme (see Download section below) presents four options to offset the systemic disadvantage faced by women in health and medical research, as reflected in the attrition of female applicants with seniority in the Investigator Grant scheme.

  • Report
  • Current
decorative image

Embryo Research Licensing Committee Report to Parliament – 1 September 2021 to 28 February 2022

The 39th biannual report

  • Embryo Research Licensing Report
  • Current
decorative image

Gain-of-Function Research Review: Report

At the request of the Minister for Health and Aged Care, the National Health and Medical Research Council has undertaken a review of gain-of-function research in Australia.

The Executive Summary from the review report, and a copy of the full report, is available below.

  • Report
  • Current
decorative image

Embryo Research Licensing Committee Report to Parliament - 1 March to 31 August 2021

The 38th biannual report

  • Embryo Research Licensing Report

Investigating clinician researcher career pathways

This report was initiated by NHMRC’s Health Translation Advisory Committee. It contains the results of three connected research projects conducted between 2018 and 2019 which NHMRC commissioned to better understand the career pathways of clinician researchers.

  • Report
  • Current

Report on qualitative research about career pathways for Aboriginal and Torres Strait Islander clinician researchers

Clinician researchers are health professionals engaged in both patient care and research. 
As such, they are uniquely placed to provide insights into their clinical practice and research, implementing evidence-based, best practice for their patients, and addressing clinically relevant problems through research. 

The Health Translation Advisory Committee (HTAC) and the National Health and Medical Research Council (NHMRC) have previously explored concerns related to clinician researcher career pathways through a research project undertaken by ORIMA Research in 20191; however only 1% of research respondents identified as Aboriginal or Torres Strait Islander. As such, the NHMRC’s Principal Committee Indigenous Caucus (PCIC) and HTAC identified the need to undertake a project specifically with Aboriginal and Torres Strait Islander clinician researchers, to better understand their specific career experiences, enablers and barriers, as well as supports required to attract and retain this audience as clinician researchers.

  • Report
  • Current

Survey of clinician researchers: Survey findings Report

Clinicians who combine clinical practice with research are an increasingly important, 
but poorly understood, strategic resource for the translation of research into practice. There is limited information available about the career pathways of clinician researchers, and the reasons why some clinicians leave or choose not to enter research.

  • Report
  • Current

Telephone Interviews Summary Report

The Investigating Clinician Researcher Career Pathways Project (the project) was initiated as a priority project by National Health and Medical Research Council (NHMRC) Health Translation Advisory Committee (HTAC) during its 2015–2018 triennium. HTAC is a principal committee of NHMRC and provides advice to the CEO and Council of NHMRC on opportunities to improve health outcomes in areas including clinical care, public, population and environmental health and prevention of illness through effective translation of research into health care and clinical practice. The results of the project will assist HTAC in making recommendations to the CEO on the training and career pathways for clinician researchers.

  • Report
  • Current

Annual Report 2020-21

This report contains information on NHMRC administration and performance, and a record of our activities for the reporting period 2020–21.

An accessible version of this document is available on the Transparency Portal.

  • Annual report

NHMRC Corporate Plan 2021–22

The NHMRC Corporate Plan 2021–22 presents our national strategy for health and medical research aligned with our three strategic purposes of investment, translation and integrity. The plan includes updated strategic priorities and health priorities and outlines our planned key activities in 2021–22 and over the next four years. The plan also describes the operating context in which we work and our performance criteria and targets for the next four years.

  • Corporate Plan
decorative image

Embryo Research Licensing Committee Report to Parliament - 1 September 2020 to 28 February 2021

The 37th biannual report

  • Embryo Research Licensing Report
  • Current

Evidence-practice policy gap (EPPG) - Indigenous

Aboriginal and Torres Strait Islander health evidence-practice policy gap reports

  • Report
  • Current

10 of the Best – Twelfth Edition

10 of the Best NHMRC research projects – Twelfth Edition describes 10 Australian health and medical research projects chosen from among the thousands of NHMRC-funded medical research projects underway in Australia.

  • 10 of the Best
decorative image

Embryo Research Licensing Committee Report to Parliament - 1 March 2020 to 31 August 2020

The 36th biannual report

  • Embryo Research Licensing Report
Abstract city lights in the night

Australian guidelines to reduce health risks from drinking alcohol

This page provides access to the full guidelines and the underlying evidence base.

A plain English summary and resources to help you apply the guidelines in daily life are available on alcohol health advice.

The guidelines provide health professionals, policy makers and the Australian community with evidence-based advice on the health effects of drinking alcohol. The guidelines aim to help individuals make informed decisions about drinking alcohol. The guidelines are also intended to form the evidence base for policy making and educational materials.

  • Guideline
  • Current

Annual Report 2019-20

This report contains information on NHMRC administration and performance, and a record of our activities for the reporting period 2019–20.

An accessible version of this document is available on the Transparency Portal.

  • Annual report

NHMRC Corporate Plan 2020-21

The NHMRC Corporate Plan 2020-21 covers the four years to 2023-24. In line with legislated requirements, it identifies major health issues likely to arise, how NHMRC will deal with these issues (including the continuing impact of COVID-19) and our strategy for health and medical research. It also details the key activities NHMRC will undertake to achieve our purposes, and the operating context in which we work, comprising: environment, capability, risk oversight and management, and organisations NHMRC cooperates with to achieve our purposes.

  • Corporate Plan
  • Current

We have published a wealth of information on Australian health and medical research, and on specific issues relating to Australian health and health care. These include statements, strategies, guidelines and other reports – all of which are publicly available.